HPLC Peptide Testing
HPLC peptide testing is a lab method used to measure peptide purity, the percent printed on a COA.
Paste this code into your page. It shows the COA field explainer with one plain credit link.
Learn
The short version
HPLC stands for high performance liquid chromatography. It pushes a dissolved sample through a packed column. Different parts of the sample stick to the column more or less, so they come out at different times. A detector at the end draws a peak for each part.
The result is a trace called a chromatogram. The purity percent comes from the areas of those peaks. The peptide purity page explains the math. This page explains the run.
Sources: US Pharmacopeia chapter 621, Chromatography, 2022 text, for how chromatography splits a sample and for purity from peak areas; Mant and others, 2007, for HPLC of peptides.
How an HPLC run works
The US Pharmacopeia (USP) describes chromatography as a way to split a sample between two phases. One phase stays put. The other moves. Parts that cling to the still phase move slower.
- The mobile phase. For peptides this is often water with a little trifluoroacetic acid (TFA), mixed with more and more acetonitrile over the run.
- The column. A steel tube packed with tiny beads. For peptides, the beads usually carry an oily coating. This is called reversed phase HPLC.
- The gradient. As the share of acetonitrile rises, peptides let go of the beads one by one. More water-loving peptides come out first.
- The detector. A UV light meter reads what comes out, moment by moment.
- The software. It draws the chromatogram and measures the area under each peak.
Sources: US Pharmacopeia chapter 621, Chromatography, public introduction, for the two phases; Mant and others, 2007, for how a peptide run is set up.
Why the wavelength matters
Peptide bonds, the links between amino acids, absorb UV light strongly below 220 nm. That is why labs usually read peptides at 210 to 220 nm. At that range, the detector reads the peptide bond itself.
Some amino acids also absorb at 250 to 290 nm. These are tyrosine, phenylalanine and tryptophan, the ones with a ring. Not every peptide has them. So a run read only at 254 or 280 nm can miss peptide pieces that lack a ring. The purity can then read higher than it would at 214 nm.
That is why a full COA names the wavelength.
Sources: Mant and others, HPLC Analysis and Purification of Peptides, 2007, for where the peptide bond and the ring amino acids absorb UV light.
What HPLC cannot show
HPLC splits a sample into parts. It does not name them.
- Identity. A peak at the expected time is a hint, not proof. EU guidance for peptide medicines suggests at least two different methods to confirm identity, such as mass and retention time.
- Hidden impurities. Two molecules can come out at the same moment and share one peak. The FDA and ICH guide on method checks, called Q2(R2), says a method should show it can tell apart the two parts that come out closest together.
- Weight of peptide in the powder. An area percent does not count water or salt in the powder. See peptide testing for the content test.
Sources: European Medicines Agency guideline on synthetic peptides, 2025, section 4.4.2, for identity; FDA and ICH Q2(R2), Validation of Analytical Procedures, 2024, section 3.1, for telling two parts apart.
HPLC vs mass spec
| HPLC with UV | Mass spectrometry (MS) | |
|---|---|---|
| What it measures | How much UV light each part absorbs as it comes out | The mass to charge ratio (m/z) of ions |
| Main use on a COA | Purity percent | A mass to compare with the molecule's mass, as one part of identity |
| What it misses | Names of the peaks | The share of each part |
The two can be joined in one run, called LC-MS. The column splits the sample, and the mass detector reads each part. The COA peptide checker compares a COA's mass with published values from PubChem.
Sources: US Pharmacopeia chapters 621 and 736, public introductions, for what chromatography and mass spectrometry each measure; Mant and others, 2007, for reading peptides by UV light; European Medicines Agency guideline on synthetic peptides, 2025, which lists LC-MS; PubChem for the checker's published masses.
What to look for on the COA
- The method: HPLC or UPLC.
- The column and the gradient, if the lab lists them.
- The wavelength, such as 210 to 220 nm.
- The chromatogram with the main peak marked.
- A limit next to the result.
The certificate of analysis page shows where each of these sits on the page.
Sources: Mant and others, 2007, for the 210 to 220 nm range, the column and the gradient of a peptide run; FDA Q7 guidance, 2016, paragraph 11.42, for a limit beside each result.
Questions
What is HPLC peptide testing?
HPLC peptide testing is a lab method that splits a dissolved peptide sample into parts in a packed column. A UV detector draws a peak for each part. The purity percent is how much of the included peak area falls in the main peak.
What is the difference between HPLC and mass spec?
HPLC splits a sample into parts and shows how much UV light each part absorbs, which gives a purity percent. Mass spectrometry measures the mass to charge ratio of ions, which gives a mass to compare with the expected one. Neither alone establishes identity. Labs can use both together as LC-MS.
How does HPLC determine purity?
The detector draws a peak for each part of the sample. Software measures the area under each peak. Purity is the main peak's area divided by the area of the included peaks, times 100, at the wavelength the lab used. The lab leaves solvent, reagent, mobile phase and matrix peaks out of the count. Peaks at or below its set cutoff are left out as well.
What is peak purity in HPLC?
Peak purity is a check that one peak holds only one compound. A detector that records a full UV spectrum can compare spectra across the peak. If they differ, another compound may share it. The FDA and ICH method guide names spectrum comparison as one way to check.
Sources: FDA and ICH Q2(R2), 2024, section 3.1, for comparing spectra; US Pharmacopeia chapter 736, public introduction, for mass to charge; US Pharmacopeia chapter 621, Chromatography, 2022 text, for the area percent and the peaks not counted; Mant and others, 2007, for peaks read by UV; European Medicines Agency guideline on synthetic peptides, 2025, which lists LC-MS.
Sources
7 sources with read dates
- HPLC Analysis and Purification of Peptides, Mant CT and others, Methods Mol Biol 2007, PMID 18604941; full text read on PubMed Central (PMC7119934), read 2026-10-06
- General Chapter 621, Chromatography, United States Pharmacopeia, public introduction read 2026-10-06
- General Chapter 621, Chromatography, harmonized text official 1 December 2022, United States Pharmacopeia; the copy of USP's own file kept by the Internet Archive on 7 December 2023, normalization procedure, read 2026-10-08
- Q2(R2) Validation of Analytical Procedures, FDA and ICH, March 2024, section 3.1, read 2026-10-06
- Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients, FDA, September 2016, paragraph 11.42, read 2026-10-06
- Guideline on the Development and Manufacture of Synthetic Peptides, European Medicines Agency, EMA/CHMP/CVMP/QWP/367182/2025, section 4.4.2, read 2026-10-06
- General Chapter 736, Mass Spectrometry, United States Pharmacopeia, public introduction read 2026-10-06